NCT01243567 - Safety and Efficacy of Bimatoprost/Timolol Fixed Combination Versus Latanoprost in Patients With Open-Angle Glaucoma Who Have Never Been Treated | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 1, 2010

Primary Completion Date

February 14, 2012

Study Completion Date

February 14, 2012

Conditions

Glaucoma, Open-Angle

Interventions

DRUG

bimatoprost 0.03%/timolol 0.5% combination ophthalmic solution

Bimatoprost 0.03%/timolol 0.5% combination ophthalmic solution (GANfort®) administered to each eye requiring treatment, once daily in the evening for 3 months.

DRUG

latanoprost 0.005% ophthalmic solution

Latanoprost 0.005% ophthalmic solution (Xalatan®) administered to each eye requiring treatment, once daily in the evening for 3 months.

Trial Locations (2)

Unknown

Coimbra

Madrid